Akshay Vaishnaw, President at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 7,804 shares at $186.39 ($1.4M) on 2023-08-04, disclosed to the SEC on 2023-08-07.
Open-market sale of $1.4M ALNY by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $184.70 | 771 | $142K | 9.8% |
| 2 | $184.70 | 771 | $142K | 9.8% |
| 3 | $185.54 | 1,869 | $347K | 23.9% |
| 4 | $185.54 | 1,869 | $347K | 23.9% |
| 5 | $186.39 | 1,107 | $206K | 14.2% |
| 6 | $186.39 | 1,107 |
| $206K |
| 14.2% |
| 7 | $187.37 | 101 | $19K | 1.3% |
| 8 | $188.40 | 17 | $3K | 0.2% |
| 9 | $189.31 | 192 | $36K | 2.5% |
| Total | $185.74 avg | 7,804 | $1.4M | 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $353K | — | Filing → |
| ALNY | SELL | 2023-04-28 | $839K | — | Filing → |
| ALNY | SELL | 2023-02-14 | $16.4M | — | Filing → |